Treatment with omalizumab offers modest protection from allergic reactions to individuals with multiple food allergies, and ...
An update from Gain Therapeutics ( ($GANX) ) is now available. On December 18, 2025, Gain Therapeutics reported exploratory endpoint data from ...
Most big Australian charities are using commercial profiling to ask for the right amount of money at the right time. But it’s ...
ThoughtSpot is at the heart of new 'modern data stack' helping UK food brand Huel find answers more quickly than it used to with Business Intelligence ...
Objective To determine whether a full-scale randomised control trial (RCT) assessing the efficacy and cost-effectiveness of a ...
Immunome shares trade higher on Monday after the company announced results from the global pivotal Phase 3 RINGSIDE trial of varegcasetat and met its primary endpoint.
Immunome (IMNM) surges after positive phase 3 results for varegacestat in desmoid tumors. Read the latest analysis on the ...
When teams treat AI as a tool for insight rather than full automation, and keep human judgment at the center, adoption ...
Utah is setting a course to become a leader in energy production as growth continues to propel the state toward innovation ...
Researchers have long believed — and the authors of a new study hypothesized — that schizophrenics have lower brain levels of the neurotransmitter serotonin, and that those lower levels are associated ...
What is the Market Size of Atomic Layer Deposition (ALD) Coating Systems? The global market for Atomic Layer Deposition (ALD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results